MX9702506A - Suspensiones orales de sabeluzol. - Google Patents

Suspensiones orales de sabeluzol.

Info

Publication number
MX9702506A
MX9702506A MX9702506A MX9702506A MX9702506A MX 9702506 A MX9702506 A MX 9702506A MX 9702506 A MX9702506 A MX 9702506A MX 9702506 A MX9702506 A MX 9702506A MX 9702506 A MX9702506 A MX 9702506A
Authority
MX
Mexico
Prior art keywords
sabeluzole
oral suspensions
oral
suspensions
preparing
Prior art date
Application number
MX9702506A
Other languages
English (en)
Inventor
Marck Karel Josef Francois
Christine Frieda Augus Agemans
Original Assignee
Janssen Pharmaceutica Nv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Janssen Pharmaceutica Nv filed Critical Janssen Pharmaceutica Nv
Publication of MX9702506A publication Critical patent/MX9702506A/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0087—Galenical forms not covered by A61K9/02 - A61K9/7023
    • A61K9/0095—Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A61K31/4523—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems
    • A61K31/454—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems containing a five-membered ring with nitrogen as a ring hetero atom, e.g. pimozide, domperidone

Abstract

Una suspension acuosa para administracion oral que consta de sabeluzol y un vehículo farmacéuticamente aceptable, que tiene un pH en la escala de 8 a 10; procedimientos para preparar la misma.
MX9702506A 1994-10-14 1995-10-06 Suspensiones orales de sabeluzol. MX9702506A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP94202986 1994-10-14
PCT/EP1995/003966 WO1996011687A1 (en) 1994-10-14 1995-10-06 Sabeluzole oral suspensions

Publications (1)

Publication Number Publication Date
MX9702506A true MX9702506A (es) 1997-07-31

Family

ID=8217278

Family Applications (1)

Application Number Title Priority Date Filing Date
MX9702506A MX9702506A (es) 1994-10-14 1995-10-06 Suspensiones orales de sabeluzol.

Country Status (15)

Country Link
US (1) US5700814A (es)
EP (1) EP0785783A1 (es)
JP (1) JPH10511640A (es)
CN (1) CN1160348A (es)
AU (1) AU689663B2 (es)
FI (1) FI971534A0 (es)
HU (1) HUT77362A (es)
IL (1) IL115626A (es)
MX (1) MX9702506A (es)
NO (1) NO971604L (es)
NZ (1) NZ295132A (es)
RU (1) RU2141821C1 (es)
TR (1) TR199501263A2 (es)
WO (1) WO1996011687A1 (es)
ZA (1) ZA958687B (es)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5583072A (en) * 1995-06-30 1996-12-10 Siemens Components, Inc. Method of manufacturing a monolithic linear optocoupler
GB9930058D0 (en) 1999-12-20 2000-02-09 Novartis Ag Organic compounds
PL212421B1 (pl) * 2002-03-12 2012-09-28 Bristol Myers Squibb Co Kompozycja farmaceutyczna w postaci zawiesiny kwasowego leku i sposób jej wytwarzania oraz sposób maskowania gorzkiego lub innego nieprzyjemnego smaku leku
US8653055B2 (en) * 2004-09-15 2014-02-18 Teva Animal Health, Inc. Corticosteroid having low systemic absorption
US8263652B2 (en) 2007-10-31 2012-09-11 Sk Biopharmaceuticals Co., Ltd. Stabilized pediatric suspension of carisbamate

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4861785A (en) * 1984-12-03 1989-08-29 Janssen Pharmaceutica N.V. Benzoxazol-and benzothiazolamine derivatives, useful as anti-anoxic agents
ZW1992A1 (en) * 1991-02-25 1993-09-22 Janssen Pharmaceutica Nv 4-/(2-benzotiazolyl)methylamino/-b-/(3,4-difluorephenoxy)methyl/-1-piperidine ethanol
US5691201A (en) * 1993-04-26 1997-11-25 Janssen Pharmaceutica, N.V. Use of sabeluzole in chronic neurodegenerative diseases

Also Published As

Publication number Publication date
ZA958687B (en) 1997-04-14
US5700814A (en) 1997-12-23
NZ295132A (en) 1998-06-26
IL115626A0 (en) 1996-01-19
NO971604D0 (no) 1997-04-08
NO971604L (no) 1997-04-08
WO1996011687A1 (en) 1996-04-25
JPH10511640A (ja) 1998-11-10
IL115626A (en) 1999-09-22
TR199501263A2 (tr) 1996-06-21
RU2141821C1 (ru) 1999-11-27
FI971534A (fi) 1997-04-11
FI971534A0 (fi) 1997-04-11
EP0785783A1 (en) 1997-07-30
HUT77362A (hu) 1998-03-30
CN1160348A (zh) 1997-09-24
AU689663B2 (en) 1998-04-02
AU3840295A (en) 1996-05-06

Similar Documents

Publication Publication Date Title
CA2086974A1 (en) R(+)-terazosin
MX9602683A (es) Compuestos de 6-dimetilaminometil-1-fenil-ciclohexano como substancias farmaceuticamente activas.
MX9802383A (es) Derivados de pirimidina como antagonistas del receptor 5ht26.
AU668295B2 (en) N-acyl-N,N',N'-ethylenediaminetriacetic acid derivatives and process for preparing same
AU7360887A (en) Pharmacologically active 1,5-diarly-3-substituted- pyrazoles and method for synthesizing the same
ZA200201511B (en) 3(5)-amino-pyrazole derivatives, process for their preparation and their use as antitumor agents.
MXPA02001497A (es) Derivados de 3-(5)-ureido-pirazol, procedimiento para su preparacion y sus uso como agentes antitumorales.
BG102125A (en) New dolastine derivatives, their preparation and application
CY2440B1 (en) Process improvement in the synthesis of N-A3-(3-cyanopyrazolo A1,5-aUpyrimidin-7-yl)phenylU-N-ethyl-acetamide.
HUP9801676A3 (en) Novel 2,3-dioxo-1,2,3,4-tetrahydro-quinoxalinyl derivatives
HUP0002473A3 (en) Aqueous suspension for nasal administration
WO1993000094A3 (en) Use of tetrahydrobenzazepine derivatives for the treatment of portal hypertension and migraine
AU3290595A (en) An aqueous nasal suspension
EP0726237A3 (en) Silicon nitride based sintered body and method of manufacturing the same
HUP9903733A3 (en) New phenylamidine derivatives, a process for preparing the same and their use as medicaments
WO1997023240A3 (de) Konjugat, umfassend einen wirkstoff, ein polypeptid und einen polyether
EP0601909A3 (en) Dibekacin derivatives and arbekacin derivatives active against resistant bacteria, and the production thereof.
MX9702506A (es) Suspensiones orales de sabeluzol.
ZA966348B (en) Process for preparing 1,4,8,11 - tetraazacyclotetradecane.
BG106534A (en) Oral solution containing galanthamine and a sweetening agent
IL116262A0 (en) Processes for preparing ranitidine
EP0682480A4 (en) STABLE, AQUEOUS DIPEPTIDE SUSPENSIONS.
NZ324691A (en) Antineoplastic peptides
AU2886595A (en) Technetium-sulphonamide complexes, their use, pharmaceutical agents containing the latter, as well as process for the production of the complexes and agents
AU6126596A (en) 1,3,8-triaza- and 3,8-diaza-1-oxaspiro(4,5)decane derivatives